{"id":3207,"date":"2022-07-22T10:36:54","date_gmt":"2022-07-22T10:36:54","guid":{"rendered":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?p=3207"},"modified":"2022-07-26T14:56:35","modified_gmt":"2022-07-26T14:56:35","slug":"funding-successes-q2-2022","status":"publish","type":"post","link":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/","title":{"rendered":"Funding successes: Q2 2022"},"content":{"rendered":"
\n\t\t\t\t\t\n\t\t\t\t\t\t\"Fb-Button\"\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>
<\/fb:like><\/div><\/div>

\"\"<\/a><\/p>\n

Congratulations to Professor Mark Wilson on his recent funding success.<\/p>\n

Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*<\/b><\/p>\n

April 2022<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n
Proposal Dept\/Group<\/strong><\/td>\nInfoed PI Name<\/strong><\/td>\nInfoed Sponsor\u00a0<\/strong><\/td>\nInfoed Proposal Title<\/strong><\/td>\nInfoed Awarded Value (\u00a3)**<\/strong><\/td>\n<\/tr>\n
Anaesthetics<\/td>\nAnthony Gordon<\/td>\nNational Institute for Health Research<\/td>\nSepsis Trials in Critical care (SepTiC)<\/td>\n\u00a33,295,448.23<\/td>\n<\/tr>\n
Cancer<\/td>\nClaire Fletcher<\/td>\nThe Weizmann Institute of Science<\/td>\nInvestigating Long Non-Coding RNA NORAD Function in Cancer DNA Damage Response<\/td>\n\u00a335,714.28<\/td>\n<\/tr>\n
Cancer<\/td>\nJacqueline McDermott<\/td>\nGynaecology Cancer Research Fund T\/A The Eve Appeal<\/td>\nDiscovery of biomarkers for the early detection of vulval cancer and pre-cancer by spatially resolved gene expression<\/td>\n\u00a330,000.00<\/td>\n<\/tr>\n
CRUK – ICR – Imperial Convergence Science Centre<\/td>\nAxel Behrens<\/td>\nInstitute of Cancer Research<\/td>\nCancer Research UK Convergence Science Centre 2022-27<\/td>\n\u00a3971,977.23<\/td>\n<\/tr>\n
General Surgery<\/td>\nAra Darzi<\/td>\nNational Institute for Health Research<\/td>\nAn artificial intelligence system to improve the quality, efficiency and experience of breast cancer screening (Stage 2)<\/td>\n\u00a31,493,617.70<\/td>\n<\/tr>\n
General Surgery<\/td>\nBrendan Delaney<\/td>\nUniversity of Leeds<\/td>\nOptimising the evolving NHS clinical services and specialist care for Long Covid (LC)<\/td>\n\u00a3601,389.24<\/td>\n<\/tr>\n
General Surgery<\/td>\nAra Darzi<\/td>\nLondon Councils<\/td>\nCommunity Makers 2.0<\/td>\n\u00a3127,400.01<\/td>\n<\/tr>\n
General Surgery<\/td>\nJames Kinross<\/td>\nInnovate UK<\/td>\nFlomark<\/td>\n\u00a3125,892.00<\/td>\n<\/tr>\n
OG<\/td>\nMark Wilson<\/td>\nNational Institute for Health Research<\/td>\nCervical Spine Immobilisation Following Blunt Trauma\u00a0 Movement Minimisation Vs Triple Immobilisation<\/td>\n\u00a33,497,768.11<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

\"\"<\/a><\/p>\n

Congratulations to Professor Eric Aboagye\u00a0<\/strong>on his recent funding success.<\/span><\/p>\n

May 2022<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Proposal Dept\/Group<\/strong><\/td>\nInfoed PI Name<\/strong><\/td>\nInfoed Sponsor\u00a0<\/strong><\/td>\nInfoed Proposal Title<\/strong><\/td>\nInfoed Awarded Value (\u00a3)**<\/strong><\/td>\n<\/tr>\n
Anaesthetics<\/td>\nBrijesh Patel<\/td>\nRoyal Brompton & Harefield Hospitals Charity<\/td>\nHaemostasis and Immunothrombosis in Extracorporeal Circuits<\/td>\n\u00a351,996.00<\/td>\n<\/tr>\n
Cancer<\/td>\nEric Aboagye<\/td>\nRadiopharm Theranostics Limited<\/td>\nDevelopment of targeted therapeutics exploiting short chain fatty acid metabolism<\/td>\n\u00a3828,223.00<\/td>\n<\/tr>\n
Cancer<\/td>\nLaura Kenny<\/td>\nGE Medical Systems Ltd (GE Healthcare)<\/td>\nMolecular imaging of HER2 receptor expression using positron emission tomography (PET): mechanistic study of the novel [18F]-HER2-Affibody (GE226) tracer in metastatic breast cancer patients<\/td>\n\u00a3288,271.00<\/td>\n<\/tr>\n
Cancer<\/td>\nAli Salehi-Reyhani<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nCTC isolation and sequencing for clinical diagnostics<\/td>\n\u00a358,200.00<\/td>\n<\/tr>\n
Cancer<\/td>\nHector Keun<\/td>\nAstraZeneca UK Limited<\/td>\nDaphne Jackson Fellow<\/td>\n\u00a355,872.00<\/td>\n<\/tr>\n
Cancer<\/td>\nHector Keun<\/td>\nDaphne Jackson Trust<\/td>\nDaphne Jackson Fellow<\/td>\n\u00a333,950.00<\/td>\n<\/tr>\n
Cancer<\/td>\nMichael Seckl<\/td>\nCancer Treatment & Research Trust<\/td>\nRegulation of response to immunotherapy by hnRNPA1 in cancer<\/td>\n\u00a316,789.05<\/td>\n<\/tr>\n
Cancer<\/td>\nMatthew Williams<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nMicro-LENS: Co-developing & paper prototyping a patient-facing, AI-supported the LENS online imaging review platform<\/td>\n\u00a35,670.00<\/td>\n<\/tr>\n
Centre for Health Policy<\/td>\nAra Darzi<\/td>\nImperial College Health Partners Limited<\/td>\nThe Networked Data Lab<\/td>\n\u00a3109,927.00<\/td>\n<\/tr>\n
Centre for Health Policy<\/td>\nSaira Ghafur<\/td>\nThe Commonwealth Fund<\/td>\nInternational update on use of telemedicine during the COVID-19 pandemic in OECD countries: A systematic review and meta-analysis<\/td>\n\u00a386,671.83<\/td>\n<\/tr>\n
General Surgery<\/td>\nAra Darzi<\/td>\nThe Royal Marsden NHS Foundation Trust<\/td>\nCo-designing a place-based diary as an intervention to enhance breast screening uptake and health seeking behaviours in South Asian communities<\/td>\n\u00a382,000.00<\/td>\n<\/tr>\n
General Surgery<\/td>\nDaniel Leff<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nThe Use of Multi-Modal Augmented Reality for Operative Guidance in Oncoplastic Breast Surgery<\/td>\n\u00a321,984.00<\/td>\n<\/tr>\n
OG<\/td>\nGeorge Hanna<\/td>\nChelsea & Westminster Hospital NHS Foundation Trust<\/td>\nThe COlorectal BReath Analysis 2 (COBRA2) Study: Non-invasive Testing for the Diagnosis and Assessment of Colorectal Cancer<\/td>\n\u00a355,000.00<\/td>\n<\/tr>\n
Simulation Centre<\/td>\nFernando Bello<\/td>\nCW+<\/td>\n3D Printed Models for Surgical Simulation, Planning and Patient Engagement<\/td>\n\u00a349,124.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

\"\"<\/a>
\nCongratulations to Professor Christina Fotopoulou on her recent funding success.<\/span><\/p>\n

June 2022<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Proposal Dept\/Group<\/strong><\/td>\nInfoed PI Name<\/strong><\/td>\nInfoed Sponsor\u00a0<\/strong><\/td>\nInfoed Proposal Title<\/strong><\/td>\nInfoed Awarded Value (\u00a3)**<\/strong><\/td>\n<\/tr>\n
Anaesthetics<\/td>\nPadmanabhan Ramnarayan<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nValidation of 3\u2019-Deoxy-3\u2019,4\u2019-didehydro-cytidine (ddhC) as a serum marker of viral infection in critically ill children: a pilot study<\/td>\n\u00a325,878.00<\/td>\n<\/tr>\n
Cancer<\/td>\nCharlotte Bevan<\/td>\nDaphne Jackson Trust<\/td>\nDaphne Jackson Fellow<\/td>\n\u00a3113,403.14<\/td>\n<\/tr>\n
Cancer<\/td>\nChristina Fotopoulou<\/td>\nImperial Health Charity<\/td>\nThe Parasol Foundation PhD Fellowship in gynaecological<\/td>\n\u00a380,518.27<\/td>\n<\/tr>\n
Cancer<\/td>\nHector Keun<\/td>\nGlaxoSmithKline<\/td>\nIdentifying novel determinants of Niraparib\/Zejula PARP inhibitor response via integration of metabolomics and chemical proteomics<\/td>\n\u00a368,687.62<\/td>\n<\/tr>\n
Cancer<\/td>\nAnke Nijhuis<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nTargeting RNA splicing to improve PARPi response in ovarian cancer<\/td>\n\u00a349,200.00<\/td>\n<\/tr>\n
Cancer<\/td>\nEhsan Ghorani<\/td>\nUniversity College London<\/td>\nUnderstanding the immunobiology of reduced frequency immunotherapy dosing in renal cancer<\/td>\n\u00a329,915.00<\/td>\n<\/tr>\n
Cancer<\/td>\nIain McNeish<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nPredictive biomarkers in ovarian clear cell carcinoma<\/td>\n\u00a322,629.00<\/td>\n<\/tr>\n
Cancer<\/td>\nIain McNeish<\/td>\nImperial Health Charity<\/td>\nDeveloping neuro-oncology trials and research<\/td>\n\u00a315,000.00<\/td>\n<\/tr>\n
Cancer<\/td>\nEric Aboagye<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nSegmentation and O-Rads Computation to facilitate AI in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a retrospective radiomics study<\/td>\n\u00a331,144.00<\/td>\n<\/tr>\n
Cancer<\/td>\nLuca Magnani<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nDeciphering epigenetic vulnerabilities of endocrine therapy-induced dormancy to tackle relapse in hormone-dependent breast cancer<\/td>\n\u00a325,000.00<\/td>\n<\/tr>\n
General Surgery<\/td>\nEmma Carrington<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nImproving Digital and Ehealth Acceptibility in Surgery<\/td>\n\u00a340,176.00<\/td>\n<\/tr>\n
General Surgery<\/td>\nRichard Kwasnicki<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nUse of wearable sensors to quantify the impact of LYMPHA surgery on upper limb morbidity in patients with breast cancer<\/td>\n\u00a315,880.00<\/td>\n<\/tr>\n
OG<\/td>\nPiers Boshier<\/td>\nImperial College Healthcare NHS Trust- BRC Funding<\/td>\nDiscovery of new pancreatic ductal adenocarcinoma biomarkers with global urinary metabolic profiling<\/td>\n\u00a361,019.00<\/td>\n<\/tr>\n
Vascular<\/td>\nAlun Davies<\/td>\nImperial College Healthcare NHS Trust<\/td>\nIPH CRF’s<\/td>\n\u00a3245,300.92<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
** This is the total project value,\u00a0including subprojects.<\/span><\/span><\/h6>\n

*Dude, where\u2019s my grant? A disclaimer:<\/strong><\/p>\n

To ensure the quality and accuracy of the information published on this blog, we source our data directly from the College\u2019s strategic reporting dashboards, relating to FoM. This means that, typically, we only include awards on this list which have been set up on the College\u2019s grants management system, in accordance with the Joint Research Office\u2019s policies and processes. As a result, there may be a delay in promoting some awards.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Congratulations to Professor Mark Wilson on his recent funding success. Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*<\/p>\n","protected":false},"author":1648,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3207","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nFunding successes: Q2 2022 - S&C Staff Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Funding successes: Q2 2022 - S&C Staff Blog\" \/>\n<meta property=\"og:description\" content=\"Congratulations to Professor Mark Wilson on his recent funding success. Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"S&C Staff Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-22T10:36:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T14:56:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2022\/07\/Prof-Mark-Wilson.jpg\" \/>\n<meta name=\"author\" content=\"Dorcas Ishaya\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ImperialSandC\" \/>\n<meta name=\"twitter:site\" content=\"@ImperialSandC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dorcas Ishaya\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/\"},\"author\":{\"name\":\"Dorcas Ishaya\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/ff4b69c6f0533060c5af6cc272245fc9\"},\"headline\":\"Funding successes: Q2 2022\",\"datePublished\":\"2022-07-22T10:36:54+00:00\",\"dateModified\":\"2022-07-26T14:56:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/\"},\"wordCount\":909,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2022\\\/07\\\/Prof-Mark-Wilson.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/\",\"name\":\"Funding successes: Q2 2022 - S&C Staff Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2022\\\/07\\\/Prof-Mark-Wilson.jpg\",\"datePublished\":\"2022-07-22T10:36:54+00:00\",\"dateModified\":\"2022-07-26T14:56:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/ff4b69c6f0533060c5af6cc272245fc9\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2022\\\/07\\\/Prof-Mark-Wilson.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2022\\\/07\\\/Prof-Mark-Wilson.jpg\",\"width\":954,\"height\":556},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2022\\\/07\\\/22\\\/funding-successes-q2-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Funding successes: Q2 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#website\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/\",\"name\":\"S&C Staff Blog\",\"description\":\"Surgery and Cancer community news\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/ff4b69c6f0533060c5af6cc272245fc9\",\"name\":\"Dorcas Ishaya\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g\",\"caption\":\"Dorcas Ishaya\"},\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/author\\\/dishaya\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Funding successes: Q2 2022 - S&C Staff Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/","og_locale":"en_US","og_type":"article","og_title":"Funding successes: Q2 2022 - S&C Staff Blog","og_description":"Congratulations to Professor Mark Wilson on his recent funding success. Well done to all Principal Investigators and teams in the Department who have recently been awarded research grants. Here is our quarterly round-up of funding successes.*","og_url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/","og_site_name":"S&C Staff Blog","article_published_time":"2022-07-22T10:36:54+00:00","article_modified_time":"2022-07-26T14:56:35+00:00","og_image":[{"url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2022\/07\/Prof-Mark-Wilson.jpg","type":"","width":"","height":""}],"author":"Dorcas Ishaya","twitter_card":"summary_large_image","twitter_creator":"@ImperialSandC","twitter_site":"@ImperialSandC","twitter_misc":{"Written by":"Dorcas Ishaya","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#article","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/"},"author":{"name":"Dorcas Ishaya","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/ff4b69c6f0533060c5af6cc272245fc9"},"headline":"Funding successes: Q2 2022","datePublished":"2022-07-22T10:36:54+00:00","dateModified":"2022-07-26T14:56:35+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/"},"wordCount":909,"commentCount":0,"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2022\/07\/Prof-Mark-Wilson.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/","name":"Funding successes: Q2 2022 - S&C Staff Blog","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#primaryimage"},"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2022\/07\/Prof-Mark-Wilson.jpg","datePublished":"2022-07-22T10:36:54+00:00","dateModified":"2022-07-26T14:56:35+00:00","author":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/ff4b69c6f0533060c5af6cc272245fc9"},"breadcrumb":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#primaryimage","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2022\/07\/Prof-Mark-Wilson.jpg","contentUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2022\/07\/Prof-Mark-Wilson.jpg","width":954,"height":556},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2022\/07\/22\/funding-successes-q2-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/"},{"@type":"ListItem","position":2,"name":"Funding successes: Q2 2022"}]},{"@type":"WebSite","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#website","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/","name":"S&C Staff Blog","description":"Surgery and Cancer community news","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/ff4b69c6f0533060c5af6cc272245fc9","name":"Dorcas Ishaya","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ec7570fdc8b829a5a06350c184e7cfa0d70fe17f33a9766dda54d0ea25cbfae2?s=96&d=mm&r=g","caption":"Dorcas Ishaya"},"url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/author\/dishaya\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/users\/1648"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/comments?post=3207"}],"version-history":[{"count":6,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3207\/revisions"}],"predecessor-version":[{"id":3229,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3207\/revisions\/3229"}],"wp:attachment":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/media?parent=3207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/categories?post=3207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/tags?post=3207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}